Company Profile

Imbed Biosciences Inc (AKA: Imbed)
Profile last edited on: 2/4/2022      CAGE: 5YDR1      UEI: NMBYXZT12DJ4

Business Identifier: Wound dressings and surgical implants
Year Founded
2010
First Award
2012
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5520 Nobel Drive Suite 100
Fitchburg, WI 53711
   (608) 237-1523
   info@imbedbio.com
   www.imbedbio.com
Location: Single
Congr. District: 02
County: Dane

Public Profile

Spun out of the University of Wisconsin-Madison, Imbed Biosciences Inc, is a medical device company developing advanced materials for wound healing and surgical applications based on its patent-pending nanotechnologies. Coming out of several years of research by a multidisciplinary group of engineers, veterinary scientists and medical surgeons, Imbed's founders bring to the table decades of experience in clinical wound management. By leveraging its novel biomaterials platforms, Imbed is set up to have major impact on wound dressings to prevent wound infections, expedite wound closure, and ideally reduce the overall cost of managing surgical and chronic wounds. Working on advanced therapies for the treatment of burns, chronic ulcers, gastro-intestinal defects, and soft-tissue repair, the company has a portfolio of products in development based on its patented MicroLyte® Matrix technology that presents bioactive molecules on tissue surfaces to combat local pain and infections. The microscale matrix accelerates cell migration and reduces antibiotic/opioid abuse. The company is registered with U.S. FDA as a medical device manufacturer and maintains an ISO 13485 certified Quality Management System.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
20-24
Revenue Range
2M-2.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Ankit Agarwal -- Co-Founder, President and Chief Executive Officer

  Nicholas L Abbott -- Co-Founder, Chair of the Board

  Charles J Czuprynski -- Co-Founder

  Jeffrey Dalsin -- Vice President, Product

  Jonathan F McAnulty -- Co-Founder

  Christopher J Murphy -- Co-Founder

  Gaurav Pranami -- VP of R&D

  Michael J Schurr -- Co-Founder